EP1254211A4 - Production de cellules - Google Patents
Production de cellulesInfo
- Publication number
- EP1254211A4 EP1254211A4 EP01901033A EP01901033A EP1254211A4 EP 1254211 A4 EP1254211 A4 EP 1254211A4 EP 01901033 A EP01901033 A EP 01901033A EP 01901033 A EP01901033 A EP 01901033A EP 1254211 A4 EP1254211 A4 EP 1254211A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cell production
- cell
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/14—Coculture with; Conditioned medium produced by hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ509800 | 2000-01-14 | ||
AUPQ5098A AUPQ509800A0 (en) | 2000-01-14 | 2000-01-14 | Cell production |
AUPQ704500 | 2000-04-20 | ||
AUPQ7045A AUPQ704500A0 (en) | 2000-04-20 | 2000-04-20 | Cell production |
AUPQ714300 | 2000-04-27 | ||
AUPQ7143A AUPQ714300A0 (en) | 2000-04-27 | 2000-04-27 | Cell production |
PCT/AU2001/000030 WO2001051611A1 (fr) | 2000-01-14 | 2001-01-12 | Production de cellules |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1254211A1 EP1254211A1 (fr) | 2002-11-06 |
EP1254211A4 true EP1254211A4 (fr) | 2003-07-16 |
Family
ID=27158200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01901033A Withdrawn EP1254211A4 (fr) | 2000-01-14 | 2001-01-12 | Production de cellules |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1254211A4 (fr) |
CA (1) | CA2397292A1 (fr) |
WO (2) | WO2001051611A1 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
US8252280B1 (en) | 1999-08-05 | 2012-08-28 | Regents Of The University Of Minnesota | MAPC generation of muscle |
WO2002064748A2 (fr) | 2001-02-14 | 2002-08-22 | Furcht Leo T | Cellules souches adultes totipotentes, sources de ces cellules, procedes d'obtention et de maintien de ces dernieres, procedes de differentiation de ces cellules, procedes d'utilisation correspondants et cellules derivees des cellules susmentionnees |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US10638734B2 (en) | 2004-01-05 | 2020-05-05 | Abt Holding Company | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
US7250294B2 (en) | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
US7799324B2 (en) | 2001-12-07 | 2010-09-21 | Geron Corporation | Using undifferentiated embryonic stem cells to control the immune system |
JP5364224B2 (ja) | 2001-12-07 | 2013-12-11 | ジェロン・コーポレーション | ヒト胚性幹細胞に由来する造血細胞 |
EP2264146A1 (fr) | 2001-12-07 | 2010-12-22 | Geron Corporation | Cellules d'îlots de Langerhans à partir de cellules souches embryonnaires humaines |
US7285415B2 (en) | 2002-07-11 | 2007-10-23 | The Regents Of The University Of California | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
US20050101014A1 (en) | 2002-07-11 | 2005-05-12 | Keirstead Hans S. | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
US7153650B2 (en) | 2003-03-13 | 2006-12-26 | Geron Corporation | Marker system for preparing and characterizing high-quality human embryonic stem cells |
WO2005003320A2 (fr) | 2003-07-02 | 2005-01-13 | Regents Of The University Of Minnesota | Differenciation neuronale de cellules souches |
EP1809739B1 (fr) | 2004-07-13 | 2014-10-15 | Asterias Biotherapeutics, Inc. | Milieu destine a la croissance de cellules souches embryonnaires humaines |
JP5560393B2 (ja) | 2005-06-22 | 2014-07-23 | アステリアス バイオセラピューティクス インコーポレイテッド | 心筋細胞系列細胞への霊長類多能性幹細胞の分化 |
AU2006262369B2 (en) | 2005-06-22 | 2012-07-05 | Asterias Biotherapeutics, Inc. | Suspension culture of human embryonic stem cells |
US8415153B2 (en) | 2006-06-19 | 2013-04-09 | Geron Corporation | Differentiation and enrichment of islet-like cells from human pluripotent stem cells |
WO2008063675A2 (fr) | 2006-11-24 | 2008-05-29 | Regents Of The University Of Minnesota | Cellules progénitrices endothermiques |
US8513009B2 (en) | 2008-01-30 | 2013-08-20 | Geron Corporation | Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells |
KR101689124B1 (ko) | 2008-03-27 | 2016-12-23 | 아스테리아스 바이오세라퓨틱스, 인크. | 영장류 다능성 줄기 세포의 조혈계 세포로의 분화 |
GB0906424D0 (en) | 2009-04-09 | 2009-05-20 | Antoxis Ltd | Use of compounds for differentiation of cells |
US9057053B2 (en) | 2010-01-19 | 2015-06-16 | The Board Of Trustees Of The Leland Stanford Junior University | Direct conversion of cells to cells of other lineages |
EP2556147B1 (fr) | 2010-04-08 | 2018-10-03 | The University Court Of The University of Edinburgh | Cellules progénitrices chondrogènes, protocole pour la dérivation de cellules et leurs utilisations |
SI2561078T1 (sl) | 2010-04-23 | 2019-01-31 | Cold Spring Harbor Laboratory | Nove strukturno oblikovane shRNA |
GB201206773D0 (en) * | 2012-04-17 | 2012-05-30 | Cambridge Entpr Ltd | Stem cells from the mammalian neural plate |
DE202014011287U1 (de) | 2013-06-11 | 2019-02-06 | The President And Fellows Of Harvard College | SC-ß Zellen und Zusammensetzungen zur Erzeugung der Zellen |
EP4323497A1 (fr) | 2021-04-11 | 2024-02-21 | President and Fellows of Harvard College | Myocytes cardiaques et compositions et procédés de production associés |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0658194A1 (fr) * | 1992-07-27 | 1995-06-21 | California Institute Of Technology | Cellules souches neurales pluripotentes de mammifere |
DE19756864C5 (de) * | 1997-12-19 | 2014-07-10 | Oliver Brüstle | Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten |
EP1068295A4 (fr) * | 1998-04-09 | 2002-08-21 | Bresagen Ltd | Facteur de differentiation/de proliferation et de conservation des cellules et procedes d'utilisation correspondants |
-
2001
- 2001-01-12 WO PCT/AU2001/000030 patent/WO2001051611A1/fr not_active Application Discontinuation
- 2001-01-12 EP EP01901033A patent/EP1254211A4/fr not_active Withdrawn
- 2001-01-12 CA CA002397292A patent/CA2397292A1/fr not_active Abandoned
- 2001-01-12 WO PCT/AU2001/000029 patent/WO2001051610A1/fr active Application Filing
Non-Patent Citations (2)
Title |
---|
RATHJEN J ET AL: "Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors.", JOURNAL OF CELL SCIENCE. ENGLAND MAR 1999, vol. 112 ( Pt 5), March 1999 (1999-03-01), pages 601 - 612, XP000986695, ISSN: 0021-9533 * |
See also references of WO0151611A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2397292A1 (fr) | 2001-07-19 |
WO2001051610A1 (fr) | 2001-07-19 |
EP1254211A1 (fr) | 2002-11-06 |
WO2001051611A1 (fr) | 2001-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1254211A4 (fr) | Production de cellules | |
EP1333086A4 (fr) | Boite de culture cellulaire | |
GB0215401D0 (en) | Ethanol production | |
GB0016752D0 (en) | Electrochemical structure | |
AU5833701A (en) | Improved electrolytic cell | |
AU1154802A (en) | Single cell electroporation | |
AU6887001A (en) | Electrolysis cell | |
EP1420469A4 (fr) | Pile | |
GB0116057D0 (en) | Nano-electrochemical cells | |
AU1368402A (en) | Cell reprogramming | |
AU2028402A (en) | Bioproduct production | |
GB2378551B (en) | Form production system | |
AUPR095200A0 (en) | Cell production | |
GB2381945B (en) | Cell | |
AUPQ704500A0 (en) | Cell production | |
AUPQ714300A0 (en) | Cell production | |
AUPQ509800A0 (en) | Cell production | |
GB0026942D0 (en) | Cell line | |
GB0019704D0 (en) | Cell line | |
GB0020246D0 (en) | Cell lines | |
GB0020396D0 (en) | Cell differentiation | |
AUPR131600A0 (en) | Neuronal cell production | |
GB0007324D0 (en) | Cell culture | |
PL341633A1 (en) | Structural shape | |
GB0020567D0 (en) | Novel liver-derived cell line |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020809 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030530 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 12N 5/06 A Ipc: 7C 12N 5/08 B Ipc: 7C 07K 14/47 B |
|
17Q | First examination report despatched |
Effective date: 20030910 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BRESAGEN INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060420 |